BioPharma announced that its licensee Celly Nutrition Corporation, the company behind unbuzzd announced that it has engaged a leading New York Investment Bank to raise up to $10 million USD in capital and explore an initial public offering on a major US public exchange, subject to requisite regulatory approval. Quantum BioPharma Ltd. retains ownership of 25.71% of Celly Nutrition.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma’s unbuzzd™ Shows Promising Results in Clinical Trial
- Quantum Group announces results from unbuzzd trial
- Five new option listings and option delistings on January 21st
- Quantum BioPharma Closes Third Tranche Offering with Amended Terms
- Quantum BioPharma Advances Legal Actions Against Former CEO
Questions or Comments about the article? Write to editor@tipranks.com